thesis-toulmin
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q50025144-4B3E0509-781B-41FD-A580-62BAE285D57C
Q50025144-4B3E0509-781B-41FD-A580-62BAE285D57C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50025144-4B3E0509-781B-41FD-A580-62BAE285D57C
Emerging immune targets for the treatment of multiple myeloma.
P2860
Q50025144-4B3E0509-781B-41FD-A580-62BAE285D57C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50025144-4B3E0509-781B-41FD-A580-62BAE285D57C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
56c4dc7edbcd1487c94cff50c3b5eebbf27996e7
P2860
A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma.